Jagadishwar Pharmaceutical Works Profile
Key Indicators
- Authorised Capital ₹ 29.75 Cr
as on 05-07-2024
- Paid Up Capital ₹ 29.70 Cr
as on 05-07-2024
- Company Age 37 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -15.86%
(FY 2023)
- Profit -32.52%
(FY 2023)
- Ebitda 5.97%
(FY 2023)
- Net Worth 0.64%
(FY 2023)
- Total Assets 0.64%
(FY 2023)
About Jagadishwar Pharmaceutical Works
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 29.75 Cr and a paid-up capital of Rs 29.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Jagadishwar Pharmaceutical Works Limited India are Gunodhar Ghosh as CFO and Sonam Agarwal as Company Secretary. Soma Ghosh, Tulika Paul, Gunodhar Ghosh, and Two other members serve as directors at the Company.
- CIN/LLPIN
L24232AS1987PLC002803
- Company No.
002803
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
20 Nov 1987
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Guwahati, Assam, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Jagadishwar Pharmaceutical Works?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gunodhar Ghosh  | CFO | 16-Aug-2019 | Current |
| Sonam Agarwal | Company Secretary | 01-Oct-2018 | Current |
| Swapan Sarkar | Managing Director | 02-Apr-2019 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Soma Ghosh | Director | 29-Sep-2021 | Current |
| Tulika Paul | Director | 29-Sep-2021 | Current |
| Sandip Singh | Director | 01-May-2019 | Current |
Financial Performance of Jagadishwar Pharmaceutical Works.
Jagadishwar Pharmaceutical Works Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.86% decrease. The company also saw a substantial fall in profitability, with a 32.52% decrease in profit. The company's net worth moved up by a moderate rise of 0.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jagadishwar Pharmaceutical Works?
In 2023, Jagadishwar Pharmaceutical Works had a promoter holding of 10.65% and a public holding of 89.35%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Online Information Technologies LimitedActive 39 years 9 monthsSoma Ghosh, Tulika Paul and 3 more are mutual person
Logic Infotech LimitedActive 39 years 11 monthsSoma Ghosh, Tulika Paul and 3 more are mutual person
Laffan Software LimitedActive 39 years 4 monthsSoma Ghosh, Tulika Paul and 3 more are mutual person
Impala Industrial Enterprises LimitedActive 36 years 3 monthsGunodhar Ghosh, Soma Ghosh and 4 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jagadishwar Pharmaceutical Works?
Unlock and access historical data on people associated with Jagadishwar Pharmaceutical Works, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jagadishwar Pharmaceutical Works, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jagadishwar Pharmaceutical Works's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
